Qiuyan Liu

National Key Laboratory Of Immunology & Inflammation
Shanghai, 200433, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Methuosis caused by dysregulated macropinocytosis, a promising tumor therapeutic strategy.

Methuosis caused by dysregulated macropinocytosis, a promising tumor therapeutic strategy.

Journal: Pharmacological research
Published: July 25, 2025

Neoleukin-2/15-armored CAR-NK cells sustain superior therapeutic efficacy in solid tumors via c-Myc/NRF1 activation.

Neoleukin-2/15-armored CAR-NK cells sustain superior therapeutic efficacy in solid tumors via c-Myc/NRF1 activation.

Journal: Signal transduction and targeted therapy
Published: September 20, 2024

Deficiency of tumor-expressed B7-H3 augments anti-tumor efficacy of anti-PD-L1 monotherapy rather than the combined chemoimmunotherapy in ovarian cancer.

Deficiency of tumor-expressed B7-H3 augments anti-tumor efficacy of anti-PD-L1 monotherapy rather than the combined chemoimmunotherapy in ovarian cancer.

Journal: Pharmacological research
Published: September 02, 2022

RNA-binding protein ZCCHC4 promotes human cancer chemoresistance by disrupting DNA-damage-induced apoptosis.

RNA-binding protein ZCCHC4 promotes human cancer chemoresistance by disrupting DNA-damage-induced apoptosis.

Journal: Signal transduction and targeted therapy
Published: December 27, 2021

Pattern Recognition Receptors (PRRs) in Macrophages Possess Prognosis and Immunotherapy Potential for Melanoma.

Pattern Recognition Receptors (PRRs) in Macrophages Possess Prognosis and Immunotherapy Potential for Melanoma.

Journal: Frontiers in immunology
Published: August 27, 2021

Withdrawal: Blockade of Fas signaling in breast cancer cells suppresses tumor growth and metastasis via disruption of Fas signaling-initiated cancer-related inflammation.

Withdrawal: Blockade of Fas signaling in breast cancer cells suppresses tumor growth and metastasis via disruption of Fas signaling-initiated cancer-related inflammation.

Journal: The Journal of biological chemistry
Published: July 09, 2021

Deficiency of GFRα1 promotes hepatocellular carcinoma progression but enhances oxaliplatin-mediated anti-tumor efficacy.

Deficiency of GFRα1 promotes hepatocellular carcinoma progression but enhances oxaliplatin-mediated anti-tumor efficacy.

Journal: Pharmacological research
Published: June 30, 2021

Small GTPase RBJ mediates nuclear entrapment of MEK1/MEK2 in tumor progression.

Small GTPase RBJ mediates nuclear entrapment of MEK1/MEK2 in tumor progression.

Journal: Cancer cell
Published: March 10, 2021

Tumor-Induced Generation of Splenic Erythroblast-like Ter-Cells Promotes Tumor Progression.

Tumor-Induced Generation of Splenic Erythroblast-like Ter-Cells Promotes Tumor Progression.

Journal: Cell
Published: March 05, 2021

Mesenchymal stem cell‑derived extracellular vesicles promote the in vitro proliferation and migration of breast cancer cells through the activation of the ERK pathway.

Mesenchymal stem cell‑derived extracellular vesicles promote the in vitro proliferation and migration of breast cancer cells through the activation of the ERK pathway.

Journal: International journal of oncology
Published: August 10, 2018

Tumor-Induced Generation of Splenic Erythroblast-like Ter-Cells Promotes Tumor Progression.

Tumor-Induced Generation of Splenic Erythroblast-like Ter-Cells Promotes Tumor Progression.

Journal: Cell
Published: December 08, 2017

CXCR2+ MDSCs promote breast cancer progression by inducing EMT and activated T cell exhaustion.

CXCR2+ MDSCs promote breast cancer progression by inducing EMT and activated T cell exhaustion.

Journal: Oncotarget
Published: June 13, 2017
Showing 1-12 of 21

Last Updated: 09/26/2026